alrestatin has been researched along with Alloxan Diabetes in 2 studies
alrestatin: aldose reductase inhibitor; RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarges, R | 1 |
| Schnur, RC | 1 |
| Belletire, JL | 1 |
| Peterson, MJ | 1 |
| Sestanj, K | 1 |
| Bellini, F | 1 |
| Fung, S | 1 |
| Abraham, N | 1 |
| Treasurywala, A | 1 |
| Humber, L | 1 |
| Simard-Duquesne, N | 1 |
| Dvornik, D | 1 |
2 other studies available for alrestatin and Alloxan Diabetes
| Article | Year |
|---|---|
Spiro hydantoin aldose reductase inhibitors.
Topics: Aldehyde Reductase; Animals; Cattle; Diabetes Mellitus, Experimental; Hydantoins; Indicators and Rea | 1988 |
N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor.
Topics: Aldehyde Reductase; Animals; Cattle; Diabetes Mellitus, Experimental; Galactitol; Isoquinolines; Len | 1984 |